652 results on '"Behrens, Frank"'
Search Results
102. Robust Static Output-Feedback Control for MJLS with Non-Homogeneous Markov Chains: A Comparative Study Considering a Wireless Sensor Network with Time-Varying PER
103. 26248 Efficacy of secukinumab and adalimumab in psoriatic arthritis patients with moderate-to-severe plaque psoriasis: Results from the EXCEED study
104. High rates of therapeutic changes in patients with psoriatic arthritis receiving treatment with disease-modifying antirheumatic drugs: A cross-sectional study
105. MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial
106. Tumour necrosis factor inhibitor monotherapy vs combination with MTX in the treatment of PsA: a systematic review of the literature
107. Additional file 1 of Implementing an automated monitoring process in a digital, longitudinal observational cohort study
108. Efficacy and safety of secukinumab in patients with spondyloarthritis and enthesitis at the Achilles tendon: results from a phase 3b trial.
109. P189 Comparison of secukinumab versus adalimumab efficacy on skin outcomes in psoriatic arthritis: 52-week results from the EXCEED study
110. P173 Efficacy and safety of upadacitinib versus placebo and adalimumab in patients with active PsA and inadequate response to non-biologic DMARDs (SELECT-PSA-1): a double-blind, randomised controlled phase III trial
111. Spondyloarthritis
112. Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis
113. Rare Loss-of-Function Mutation in SERPINA3 in Generalized Pustular Psoriasis
114. Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysis
115. Implementing an Automated Monitoring Process in a Digital, Longitudinal Observational Cohort Study
116. Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)
117. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics
118. Observational study of a patient and doctor directed pre-referral questionnaire for an early arthritis clinic
119. Unterschiede zwischen Männern und Frauen mit Psoriasis-Arthritis und deren Korrelation mit der Hautbeteiligung: eine Querschnittsanalyse der RABBIT-SpA-Patienten
120. Longitudinale Veränderungen der ZNS-Schmerzantwort unter Therapie mit Certolizumab-Pegol (CZP) bei rheumatoider Arthritis. Eine post-hoc Analyse der PreCePRA Studie
121. Impact of long-term inflammation to develop neuropathic pain components in patients with rheumatoid arthritis. Results from deep phenotyping of pain profiles using Quantitative Sensory Testing (QST) and contact heat evoked potentials (CHEPs)
122. Evaluation of different fluorescence-optical imaging (FOI) assessment methods to differentiate clinical psoriatic arthritis from psoriasis
123. Canakinumab zur Behandlung von adultem Still Syndrom (AOSD): eine Prüfer-initiierte, multizentrische, plazebokontrollierte Studie (CONSIDER)
124. A prospective, multicentre study to determine the incidence of rheumatoid arthritis in anti-CPP positive and anti-CPP negative patients who exhibit a new onset of musculoskeletal symptoms
125. Innovative Imaging Technique for Visualization of Vascularization and Established Methods for Detection of Musculoskeletal Inflammation in Psoriasis Patients
126. Treatment-to-target with apremilast in psoriatic arthritis: the probability of achieving targets and comprehensive control of disease manifestations
127. Additional file 1 of Genetic variants in FBLIM1 gene do not contribute to SAPHO syndrome and chronic recurrent multifocal osteomyelitis in typical patient groups
128. Additional file 1 of Achilles tendon enthesitis evaluated by MRI assessments in patients with axial spondyloarthritis and psoriatic arthritis: a report of the methodology of the ACHILLES trial
129. Additional file 2 of Achilles tendon enthesitis evaluated by MRI assessments in patients with axial spondyloarthritis and psoriatic arthritis: a report of the methodology of the ACHILLES trial
130. Langanhaltende Wirksamkeit von Ustekinumab bei Patienten mit aktiver Psoriasis Arthritis bei guter Verträglichkeit - Ergebnisse der laufenden nicht-interventionellen Studie SUSTAIN
131. Patientencharakteristika und Inzidenz früher entzündlicher Veränderungen in Patienten mit neuem Auftreten unspezifischer muskuloskelettaler Beschwerden und positivem Nachweis von antiCCP-Antikörpern im Schnelltest - die PANORA Studie
132. Charakterisierung von Psoriasis-Patienten mit subklinischen Zeichen der muskuloskelettalen Entzündung ermittelt durch Fluoreszenz-optische Bildgebung und Überprüfung des Befundes mittels MRT - Analyse der prospektiven multizentrischen XCITING Studie
133. Nicht-interventionelle Studie zur Wirksamkeit und Sicherheit von Etanercept in der zielgerichteten Routinebehandlung von Patienten mit Rheumatoider Arthritis, axialer Spondyloarthritis, Psoriasis-Arthritis und Psoriasis (ADEQUATE)
134. Maritimes Supply Chain Management – Innovative Logistiklösungen für Unternehmen mit globalen Beschaffungsaktivitäten
135. Variants in RUNX3 Contribute to Susceptibility to Psoriatic Arthritis, Exhibiting Further Common Ground With Ankylosing Spondylitis
136. Subanalysis of the noninterventional study LOTOS: Improved work ability status in psoriasis patients treated with adalimumab during routine clinical care: P7130
137. Subanalysis of the noninterventional study LOTOS: Correlation between measures of disease activity and identification of treatment response predictors in psoriasis patients treated with adalimumab during routine clinical care: P7005
138. Subanalysis of the noninterventional study LOTOS: Patient-oriented outcomes in psoriasis patients treated with adalimumab during routine clinical care: P7127
139. Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial.
140. High rates of therapeutic changes in patients with psoriatic arthritis receiving treatment with disease-modifying antirheumatic drugs: A cross-sectional study.
141. Tumor necrosis factor promoter polymorphism TNF*-857 is a risk allele for psoriatic arthritis independent of the PSORS1 locus
142. Achilles tendon enthesitis evaluated by MRI assessments in patients with axial spondyloarthritis and psoriatic arthritis: a report of the methodology of the ACHILLES trial
143. Monitoring of Industrial Electrical Equipment using IoT
144. Therapiestrategien der Psoriasisarthritis
145. Canakinumab for Treatment of Adult-Onset Still’s Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial
146. Therapie der Psoriasisarthritis
147. Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial
148. Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT group
149. Aktuelle Therapie der Psoriasisarthritis
150. An automated and modified technique for testing the retinal function (Arden test) by use of the electro-oculogram (EOG) for clinical and research use
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.